infringement of United States Patent No. 6,294,197 (the
“’197 patent”) under the Patent Laws of the United States… The Patents in Suit
27. The ’197 patent was duly and lawfully issued…Lupin Inc. review(s) US patents and
seek(s) opportunities to challenge those patents.
31. On…until after the expiration of the ’197 patent, inclusive
of any patent term extensions and/or exclusivities… to Novartis regarding infringement of the ’197 patent.
15. Lupin Ltd. and Lupin Inc., acting
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.